OptiBiotix Health (OPTI) RNS Announcements

Add to Alert list
Date Time Source Announcement
24 Oct 2022 07:00 AM
RNS
Approval of GoFigure products
17 Oct 2022 07:00 AM
RNS
New health claims for SlimBiome in Australia
28 Sep 2022 07:00 AM
RNS
Half-year Report
26 Sep 2022 07:00 AM
RNS
Launch of novel prebiotic in Europe and Africa
20 Sep 2022 07:00 AM
RNS
Launch of GoFigure range with Apollo Hospitals
14 Sep 2022 07:00 AM
RNS
New commercialisation partner in Asia Pacific
24 Aug 2022 04:41 PM
RNS
Second Price Monitoring Extn
24 Aug 2022 04:35 PM
RNS
Price Monitoring Extension
24 Aug 2022 02:06 PM
RNS
Second Price Monitoring Extn
24 Aug 2022 02:00 PM
RNS
Price Monitoring Extension
24 Aug 2022 11:06 AM
RNS
Second Price Monitoring Extn
24 Aug 2022 11:00 AM
RNS
Price Monitoring Extension
24 Aug 2022 09:05 AM
RNS
Second Price Monitoring Extn
24 Aug 2022 09:00 AM
RNS
Price Monitoring Extension
24 Aug 2022 07:00 AM
RNS
Trading update
26 Jul 2022 12:31 PM
RNS
Result of AGM
20 Jul 2022 07:00 AM
RNS
Commercial and scientific update
11 Jul 2022 07:00 AM
RNS
Joint development agreement signed with Firmenich
01 Jul 2022 07:00 AM
RNS
Director Appointment and Director Dealing
28 Jun 2022 07:00 AM
RNS
Final Results
20 Jun 2022 07:00 AM
RNS
ProBiotix Health - Appointment of CEO
31 Mar 2022 07:01 AM
RNS
Admission of ProBiotix Health plc to AQSE
25 Mar 2022 02:36 PM
RNS
Director/PDMR Shareholding
18 Mar 2022 02:00 PM
RNS
Price Monitoring Extension
17 Mar 2022 07:00 AM
RNS
Intention to list ProBiotix Health on AQSE
09 Mar 2022 07:00 AM
RNS
Exercise of warrants
01 Mar 2022 07:00 AM
RNS
Commercial Appointments
28 Feb 2022 07:00 AM
RNS
Trading Update
09 Feb 2022 07:00 AM
RNS
Commercial and strategy update
01 Feb 2022 07:00 AM
RNS
Consumer study of LPLDL in Cholbiome products
27 Jan 2022 10:38 AM
RNS
Exercise of Warrants
18 Jan 2022 07:00 AM
RNS
Publication of third human study on LPLDL
07 Jan 2022 07:00 AM
RNS
Issue of options
05 Jan 2022 07:00 AM
RNS
OptiBiotix obtains BRC accreditation
15 Dec 2021 07:00 AM
RNS
Exclusive sales and distribution agreement
09 Dec 2021 07:00 AM
RNS
Launch of GoFigure range with Apollo Hospitals
01 Dec 2021 12:00 PM
RNS
Investor presentation
01 Dec 2021 07:00 AM
RNS
Launch of LeanBiome with global nutrition leader
17 Nov 2021 07:00 AM
RNS
Formation of OptiBiotix Health India
25 Oct 2021 07:00 AM
RNS
SlimBiome® Approved by Health Canada
30 Sep 2021 07:00 AM
RNS
Half-year Report
01 Sep 2021 07:00 AM
RNS
Director/PDMR Shareholding
31 Aug 2021 07:00 AM
RNS
Investor update
31 Aug 2021 07:00 AM
RNS
Director dealing
10 Aug 2021 07:00 AM
RNS
Extension of territories for Seed Health's DS-01
05 Aug 2021 07:00 AM
RNS
Trading and commercial update
09 Jul 2021 10:49 AM
RNS
Result of AGM
06 Jul 2021 07:00 AM
RNS
Further sales expansion in Asia
17 Jun 2021 07:00 AM
RNS
Final Results
19 May 2021 02:00 PM
RNS
SkinBioTherapeutics plc shareholding

OptiBiotix Health Plc is a life sciences company that develops microbiome modulators to improve human health. Headquartered in York, it develops technologies to modulate the human microbiome, which is the collective genome of the microbes in the body.

OptiBiotix Health listed on the London Stock Exchange in August 2014 under the ticker OPTI.

OPTI share price launched at 2,692p.

UK 100

Latest directors dealings